{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:00:55Z","timestamp":1760241655064,"version":"build-2065373602"},"reference-count":37,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","award":["903-2795"],"award-info":[{"award-number":["903-2795"]}],"id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Euroimmun","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"Columbia Lyme &amp; Tick-borne Diseases Research Center established by Global Lyme Alliance and the Lyme Disease Association","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>The objective was to examine the prevalence of Borrelia antibodies among symptomatic individuals with recent and past Lyme disease in endemic communities using standard assays and novel assays employing next-generation antigenic substrates. Single- and two-tiered algorithms included different anti-Borrelia ELISAs and immunoblots. Antibody prevalence was examined in sera from 32 individuals with recent erythema migrans (EM), 335 individuals with persistent symptoms following treatment for Lyme disease (PTLS), and 41 community controls without a history of Lyme disease. Among convalescent EM cases, sensitivity was highest using the C6 ELISA (93.8%) compared to other single assays; specificity was 92.7% for the C6 ELISA vs. 85.4\u201397.6% for other assays. The two-tiered ELISA-EUROLINE IgG immunoblot combinations enhanced case detection substantially compared to the respective ELISA-IgG Western blot combinations (75.0% vs. 34.4%) despite similar specificity (95.1% vs. 97.6%, respectively). For PTLS cohorts, two-tier ELISA-IgG-blot positivity ranged from 10.1% to 47.4%, depending upon assay combination, time from initial infection, and clinical history. For controls, the two-tier positivity rate was 0\u201314.6% across assays. A two-tier algorithm of two-ELISA assays yielded a high positivity rate of 87.5% among convalescent EM cases with specificity of 92.7%. For convalescent EM, combinations of the C6 ELISA with a second-tier ELISA or line blot may provide useful alternatives to WB-based testing algorithms.<\/jats:p>","DOI":"10.3390\/healthcare6020069","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T11:20:36Z","timestamp":1529407236000},"page":"69","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Community Study of Borrelia burgdorferi Antibodies among Individuals with Prior Lyme Disease in Endemic Areas"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9050-5322","authenticated-orcid":false,"given":"Barbara","family":"Strobino","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Lyme and Tick-Borne Diseases Research Center, Columbia University Irving Medical Center, New York, NY 10032, USA"},{"name":"Research Foundation for Mental Hygiene, Inc., New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Steinhagen","sequence":"additional","affiliation":[{"name":"Institute for Experimental Immunology, Euroimmun, 23560 L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Meyer","sequence":"additional","affiliation":[{"name":"Institute for Experimental Immunology, Euroimmun, 23560 L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Scheper","sequence":"additional","affiliation":[{"name":"Institute for Experimental Immunology, Euroimmun, 23560 L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-915X","authenticated-orcid":false,"given":"Sandra","family":"Saschenbrecker","sequence":"additional","affiliation":[{"name":"Institute for Experimental Immunology, Euroimmun, 23560 L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Schlumberger","sequence":"additional","affiliation":[{"name":"Institute for Experimental Immunology, Euroimmun, 23560 L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"St\u00f6cker","sequence":"additional","affiliation":[{"name":"Institute for Experimental Immunology, Euroimmun, 23560 L\u00fcbeck, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gaito","sequence":"additional","affiliation":[{"name":"Independent Researcher, Basking Ridge, NJ 07920, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A.","family":"Fallon","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Lyme and Tick-Borne Diseases Research Center, Columbia University Irving Medical Center, New York, NY 10032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed Lyme disease, United States, 2005\u20132010","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_2","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe","volume":"39","author":"Sykes","year":"2017","journal-title":"J. Public Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1574-695X.2006.00139.x","article-title":"Microbiological and serological diagnosis of Lyme borreliosis","volume":"49","author":"Wilske","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","article-title":"Lyme borreliosis","volume":"362","author":"Stanek","year":"2003","journal-title":"Lancet"},{"key":"ref_6","unstructured":"(1994, January 27\u201329). Association of State and Territorial Public Health Laboratory Directors. Proceedings of the Second National Conference on Serologic Diagnosis of Lyme Disease, Dearborn, MI, USA."},{"key":"ref_7","unstructured":"Mauch, H., and L\u00fctticken, R. (2000). Lyme-Borreliose. Qualit\u00e4tsstandards in der Mikrobiologisch-Infektiologischen Diagnostik, Urban & Fischer Verlag."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1086\/589316","article-title":"Laboratory testing for Lyme disease: Time for a change?","volume":"47","author":"Weinstein","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/jcm.35.3.537-543.1997","article-title":"Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene\/College of American Pathologists Proficiency Testing Program","volume":"35","author":"Bakken","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10096-011-1157-6","article-title":"Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots","volume":"30","author":"Ang","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/313688","article-title":"A limitation of 2-stage serological testing for Lyme disease: Enzyme immunoassay and immunoblot assay are not independent tests","volume":"30","author":"Wormser","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/648674","article-title":"2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test","volume":"50","author":"Branda","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/cir464","article-title":"Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay","volume":"53","author":"Branda","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/589242","article-title":"Prospective study of serologic tests for lyme disease","volume":"47","author":"Steere","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1128\/CVI.00195-08","article-title":"Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease","volume":"15","author":"Ledue","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10067-014-2706-z","article-title":"Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: Acute and convalescent serology among a prospective cohort of early Lyme disease patients","volume":"34","author":"Rebman","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/cid\/ciu703","article-title":"A comparison of lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment","volume":"59","author":"Fallon","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","first-page":"591","article-title":"Quality of Lyme disease serology. Lessons from the German Proficiency Testing Program 1999\u20132001. A preliminary report","volume":"114","author":"Hunfeld","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/JCM.38.6.2097-2102.2000","article-title":"A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis","volume":"38","author":"Robertson","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1128\/JCM.37.12.3990-3996.1999","article-title":"Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE","volume":"37","author":"Liang","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/374395","article-title":"Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates","volume":"187","author":"Bacon","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1128\/JCM.43.8.3602-3609.2005","article-title":"Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues","volume":"43","author":"Goettner","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1128\/JCM.41.3.1299-1303.2003","article-title":"Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis","volume":"41","author":"Lehnert","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1099\/0022-1317-51-8-649","article-title":"Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis","volume":"51","author":"Magnarelli","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1128\/JCM.02111-15","article-title":"Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease","volume":"53","author":"Lahey","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Pomelova, V.G., Korenberg, E.I., Kuznetsova, T.I., Bychenkova, T.A., Bekman, N.I., and Osin, N.S. (2015). C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130048"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CVI.00685-15","article-title":"Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease","volume":"23","author":"Embers","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_28","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Surveillance for Lyme Disease-United States, 1992\u20132006","volume":"57","author":"Bacon","year":"2008","journal-title":"MMWR Surveill. Summ."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JCM.00874-16","article-title":"Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples","volume":"54","author":"Molins","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/cit235","article-title":"Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe","volume":"57","author":"Branda","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cid\/cix043","article-title":"Evaluation of modified 2-tiered serodiagnostic testing algorithms for early Lyme disease","volume":"64","author":"Branda","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","article-title":"Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease","volume":"75","author":"Wormser","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/ciw427","article-title":"Evaluation of the C6 Lyme enzyme immunoassay for the diagnosis of Lyme disease in children and adolescents","volume":"63","author":"Lipsett","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00430-013-0315-0","article-title":"Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa","volume":"203","author":"Wormser","year":"2014","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12967-015-0701-z","article-title":"Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis","volume":"13","author":"Magni","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/ciw112","article-title":"Detection of IFN-Y secretion by T Cells collected before and after successful treatment of early Lyme disease","volume":"62","author":"Callister","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Embers, M.E., Barthold, S.W., Borda, J.T., Bowers, L., Doyle, L., Hodzic, E., Jacobs, M.B., Hasenkampf, N.R., Martin, D.S., and Narasimhan, S. (2012). Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection. PLoS ONE, 7.","DOI":"10.1371\/annotation\/4cafed66-fb84-4589-a001-131d9c50aea6"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/6\/2\/69\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:09:15Z","timestamp":1760195355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/6\/2\/69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["healthcare6020069"],"URL":"https:\/\/doi.org\/10.3390\/healthcare6020069","relation":{},"ISSN":["2227-9032"],"issn-type":[{"type":"electronic","value":"2227-9032"}],"subject":[],"published":{"date-parts":[[2018,6,19]]}}}